M-m-r II vaccine vials
Ended Awarded
- Contract number
- SPE2DB25FXSQN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,054
Award facts
- Contract value 100% obligated
- $7,053.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, valued at $7,053.84 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies, including vaccines, specialty medications, generic and brand-name drugs, and medical devices across multiple therapeutic domains. All prior contract awards reviewed were competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement requirements. The DLA Troop Support is advancing toward establishing Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple anticipated awards across separate regions, positioning AmerisourceBergen to continue supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXSQN?
SPE2DB25FXSQN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FXSQN worth?
The government has obligated $7,054 on SPE2DB25FXSQN.
Is contract SPE2DB25FXSQN an order under another contract?
Yes. SPE2DB25FXSQN is a delivery order under SPE2DB25D7060, an indefinite delivery contract.
Was contract SPE2DB25FXSQN competed?
The extent of competition for SPE2DB25FXSQN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award